The ethical drug company Novo Nordisk will report earnings on Wednesday, January 31. Analysts expect the company to report EPS of $0.67 on revenue of $8.7 billion. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Tags:$NVO Share: Mark W. Guthner, CFA Previous Post Economy & the Cost of Government BorrowingNext PostThe Week Ahead | 1/29/2024 You Might Also Like Campbell Soup Company: CPB September 12, 2023 Bull Trap or Hesitation Before the Next Leg Higher June 25, 2019 SLV: Has Silver Lost Its Shine or Is It the Comeback Kid? June 2, 2020
You Might Also Like Campbell Soup Company: CPB September 12, 2023 Bull Trap or Hesitation Before the Next Leg Higher June 25, 2019 SLV: Has Silver Lost Its Shine or Is It the Comeback Kid? June 2, 2020
